6-135053230-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006620.4(HBS1L):​c.43+1419G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.466 in 151,932 control chromosomes in the GnomAD database, including 16,862 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.47 ( 16862 hom., cov: 31)

Consequence

HBS1L
NM_006620.4 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.350

Publications

7 publications found
Variant links:
Genes affected
HBS1L (HGNC:4834): (HBS1 like translational GTPase) This gene encodes a member of the GTP-binding elongation factor family. It is expressed in multiple tissues with the highest expression in heart and skeletal muscle. The intergenic region of this gene and the MYB gene has been identified to be a quantitative trait locus (QTL) controlling fetal hemoglobin level, and this region influnces erythrocyte, platelet, and monocyte counts as well as erythrocyte volume and hemoglobin content. DNA polymorphisms at this region associate with fetal hemoglobin levels and pain crises in sickle cell disease. A single nucleotide polymorphism in exon 1 of this gene is significantly associated with severity in beta-thalassemia/Hemoglobin E. Multiple alternatively spliced transcript variants encoding different protein isoforms have been found for this gene. [provided by RefSeq, May 2009]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006620.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.546 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006620.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBS1L
NM_006620.4
MANE Select
c.43+1419G>C
intron
N/ANP_006611.1Q9Y450-1
HBS1L
NM_001145158.2
c.43+1419G>C
intron
N/ANP_001138630.1Q9Y450-4
HBS1L
NM_001145207.2
c.43+1419G>C
intron
N/ANP_001138679.1Q9Y450-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
HBS1L
ENST00000367837.10
TSL:1 MANE Select
c.43+1419G>C
intron
N/AENSP00000356811.5Q9Y450-1
HBS1L
ENST00000367822.9
TSL:1
c.43+1419G>C
intron
N/AENSP00000356796.5Q9Y450-2
HBS1L
ENST00000949311.1
c.43+1419G>C
intron
N/AENSP00000619370.1

Frequencies

GnomAD3 genomes
AF:
0.466
AC:
70807
AN:
151814
Hom.:
16843
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.369
Gnomad AMI
AF:
0.348
Gnomad AMR
AF:
0.480
Gnomad ASJ
AF:
0.472
Gnomad EAS
AF:
0.530
Gnomad SAS
AF:
0.563
Gnomad FIN
AF:
0.585
Gnomad MID
AF:
0.427
Gnomad NFE
AF:
0.495
Gnomad OTH
AF:
0.451
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.466
AC:
70858
AN:
151932
Hom.:
16862
Cov.:
31
AF XY:
0.472
AC XY:
35015
AN XY:
74246
show subpopulations
African (AFR)
AF:
0.368
AC:
15259
AN:
41438
American (AMR)
AF:
0.481
AC:
7342
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.472
AC:
1637
AN:
3470
East Asian (EAS)
AF:
0.531
AC:
2743
AN:
5168
South Asian (SAS)
AF:
0.564
AC:
2714
AN:
4814
European-Finnish (FIN)
AF:
0.585
AC:
6155
AN:
10524
Middle Eastern (MID)
AF:
0.421
AC:
123
AN:
292
European-Non Finnish (NFE)
AF:
0.495
AC:
33608
AN:
67948
Other (OTH)
AF:
0.457
AC:
962
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1934
3867
5801
7734
9668
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.487
Hom.:
2262
Bravo
AF:
0.451
Asia WGS
AF:
0.559
AC:
1944
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
7.0
DANN
Benign
0.66
PhyloP100
-0.35
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7741515;
hg19: chr6-135374368;
COSMIC: COSV59020038;
COSMIC: COSV59020038;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.